nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM1—Metabolism—GNAS—bile duct cancer	0.000399	0.000399	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TGFB1—bile duct cancer	0.000395	0.000395	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFBR2—bile duct cancer	0.000392	0.000392	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—NRAS—bile duct cancer	0.00039	0.00039	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—NRAS—bile duct cancer	0.000383	0.000383	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TGFB1—bile duct cancer	0.000382	0.000382	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TGFB1—bile duct cancer	0.000382	0.000382	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—GNAS—bile duct cancer	0.000378	0.000378	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000376	0.000376	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SMAD4—bile duct cancer	0.000371	0.000371	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—NRAS—bile duct cancer	0.00037	0.00037	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—NRAS—bile duct cancer	0.00037	0.00037	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—NRAS—bile duct cancer	0.000368	0.000368	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—KRAS—bile duct cancer	0.000366	0.000366	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOS2—bile duct cancer	0.00036	0.00036	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFBR2—bile duct cancer	0.000358	0.000358	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TP53—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—EGFR—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—NRAS—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—NRAS—bile duct cancer	0.000356	0.000356	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—KRAS—bile duct cancer	0.000354	0.000354	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—KRAS—bile duct cancer	0.000354	0.000354	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—NRAS—bile duct cancer	0.000352	0.000352	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—EGFR—bile duct cancer	0.000349	0.000349	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOS2—bile duct cancer	0.000348	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOS2—bile duct cancer	0.000348	0.000348	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—NRAS—bile duct cancer	0.000348	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000346	0.000346	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFBR2—bile duct cancer	0.000346	0.000346	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—GNAS—bile duct cancer	0.000345	0.000345	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—HRAS—bile duct cancer	0.000341	0.000341	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SMAD4—bile duct cancer	0.000339	0.000339	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—EGFR—bile duct cancer	0.000337	0.000337	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—EGFR—bile duct cancer	0.000337	0.000337	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—KRAS—bile duct cancer	0.000336	0.000336	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—EGFR—bile duct cancer	0.000335	0.000335	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—GNAS—bile duct cancer	0.000334	0.000334	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—GNAS—bile duct cancer	0.000334	0.000334	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—KRAS—bile duct cancer	0.000329	0.000329	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—NRAS—bile duct cancer	0.000329	0.000329	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SMAD4—bile duct cancer	0.000327	0.000327	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SMAD4—bile duct cancer	0.000327	0.000327	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TP53—bile duct cancer	0.000325	0.000325	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—NRAS—bile duct cancer	0.000324	0.000324	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—EGFR—bile duct cancer	0.000324	0.000324	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—EGFR—bile duct cancer	0.000324	0.000324	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—EGFR—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—KRAS—bile duct cancer	0.000319	0.000319	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—KRAS—bile duct cancer	0.000319	0.000319	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—EGFR—bile duct cancer	0.000317	0.000317	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—KRAS—bile duct cancer	0.000316	0.000316	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TP53—bile duct cancer	0.000315	0.000315	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TP53—bile duct cancer	0.000315	0.000315	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—HRAS—bile duct cancer	0.000311	0.000311	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PTGS2—bile duct cancer	0.000307	0.000307	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—KRAS—bile duct cancer	0.000306	0.000306	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—KRAS—bile duct cancer	0.000306	0.000306	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—KRAS—bile duct cancer	0.000303	0.000303	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—ERBB2—bile duct cancer	0.000303	0.000303	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—HRAS—bile duct cancer	0.000301	0.000301	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—HRAS—bile duct cancer	0.000301	0.000301	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—EGFR—bile duct cancer	0.0003	0.0003	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—KRAS—bile duct cancer	0.0003	0.0003	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PTGS2—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—EGFR—bile duct cancer	0.000295	0.000295	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—ERBB2—bile duct cancer	0.000293	0.000293	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—NRAS—bile duct cancer	0.000288	0.000288	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTGS2—bile duct cancer	0.000287	0.000287	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—HRAS—bile duct cancer	0.000286	0.000286	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—ERBB2—bile duct cancer	0.000283	0.000283	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—ERBB2—bile duct cancer	0.000283	0.000283	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—KRAS—bile duct cancer	0.000283	0.000283	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HRAS—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—KRAS—bile duct cancer	0.000279	0.000279	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—ERBB2—bile duct cancer	0.000274	0.000274	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—bile duct cancer	0.000273	0.000273	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HRAS—bile duct cancer	0.000271	0.000271	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HRAS—bile duct cancer	0.000271	0.000271	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—ERBB2—bile duct cancer	0.000271	0.000271	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—ERBB2—bile duct cancer	0.00027	0.00027	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HRAS—bile duct cancer	0.000269	0.000269	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—bile duct cancer	0.000268	0.000268	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—NRAS—bile duct cancer	0.000267	0.000267	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTGS2—bile duct cancer	0.000265	0.000265	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—EGFR—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—ERBB2—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—ERBB2—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HRAS—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HRAS—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—bile duct cancer	0.00026	0.00026	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—bile duct cancer	0.000259	0.000259	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—bile duct cancer	0.000259	0.000259	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—HRAS—bile duct cancer	0.000258	0.000258	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—bile duct cancer	0.000256	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—bile duct cancer	0.000256	0.000256	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—ERBB2—bile duct cancer	0.000256	0.000256	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—HRAS—bile duct cancer	0.000255	0.000255	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—ERBB2—bile duct cancer	0.000252	0.000252	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000248	0.000248	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—KRAS—bile duct cancer	0.000248	0.000248	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—bile duct cancer	0.000247	0.000247	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—NRAS—bile duct cancer	0.000244	0.000244	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—bile duct cancer	0.000244	0.000244	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—EGFR—bile duct cancer	0.000244	0.000244	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—bile duct cancer	0.000243	0.000243	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HRAS—bile duct cancer	0.000241	0.000241	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HRAS—bile duct cancer	0.000237	0.000237	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—NRAS—bile duct cancer	0.000236	0.000236	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—NRAS—bile duct cancer	0.000236	0.000236	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—bile duct cancer	0.000232	0.000232	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NRAS—bile duct cancer	0.000231	0.000231	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—bile duct cancer	0.000231	0.000231	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—KRAS—bile duct cancer	0.00023	0.00023	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—bile duct cancer	0.000227	0.000227	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ERBB2—bile duct cancer	0.000224	0.000224	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—NRAS—bile duct cancer	0.000223	0.000223	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—EGFR—bile duct cancer	0.000222	0.000222	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—bile duct cancer	0.000222	0.000222	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—bile duct cancer	0.000219	0.000219	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—bile duct cancer	0.000216	0.000216	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—NRAS—bile duct cancer	0.000216	0.000216	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—NRAS—bile duct cancer	0.000216	0.000216	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—EGFR—bile duct cancer	0.000215	0.000215	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—EGFR—bile duct cancer	0.000215	0.000215	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—bile duct cancer	0.000214	0.000214	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—bile duct cancer	0.000214	0.000214	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TGFB1—bile duct cancer	0.000214	0.000214	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HRAS—bile duct cancer	0.000211	0.000211	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EGFR—bile duct cancer	0.00021	0.00021	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—KRAS—bile duct cancer	0.00021	0.00021	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NRAS—bile duct cancer	0.000208	0.000208	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ERBB2—bile duct cancer	0.000208	0.000208	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NRAS—bile duct cancer	0.000206	0.000206	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NRAS—bile duct cancer	0.000206	0.000206	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—KRAS—bile duct cancer	0.000203	0.000203	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—KRAS—bile duct cancer	0.000203	0.000203	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EGFR—bile duct cancer	0.000203	0.000203	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—bile duct cancer	0.000202	0.000202	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NRAS—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NRAS—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—KRAS—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EGFR—bile duct cancer	0.000197	0.000197	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EGFR—bile duct cancer	0.000197	0.000197	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—bile duct cancer	0.000196	0.000196	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NRAS—bile duct cancer	0.000195	0.000195	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000193	0.000193	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KRAS—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NRAS—bile duct cancer	0.000191	0.000191	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—bile duct cancer	0.000191	0.000191	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—bile duct cancer	0.000191	0.000191	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EGFR—bile duct cancer	0.00019	0.00019	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ERBB2—bile duct cancer	0.000189	0.000189	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EGFR—bile duct cancer	0.000188	0.000188	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EGFR—bile duct cancer	0.000187	0.000187	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—bile duct cancer	0.000187	0.000187	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—bile duct cancer	0.000186	0.000186	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—bile duct cancer	0.000186	0.000186	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—bile duct cancer	0.000185	0.000185	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ERBB2—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ERBB2—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EGFR—bile duct cancer	0.000181	0.000181	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EGFR—bile duct cancer	0.000181	0.000181	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—bile duct cancer	0.000181	0.000181	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—bile duct cancer	0.000179	0.000179	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—bile duct cancer	0.000179	0.000179	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—bile duct cancer	0.000178	0.000178	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—bile duct cancer	0.000178	0.000178	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EGFR—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—bile duct cancer	0.000176	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EGFR—bile duct cancer	0.000174	0.000174	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—bile duct cancer	0.000173	0.000173	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—bile duct cancer	0.000173	0.000173	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—bile duct cancer	0.000171	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—bile duct cancer	0.000171	0.000171	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—bile duct cancer	0.000171	0.000171	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NRAS—bile duct cancer	0.00017	0.00017	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—bile duct cancer	0.000169	0.000169	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—bile duct cancer	0.000167	0.000167	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—bile duct cancer	0.000163	0.000163	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—bile duct cancer	0.000163	0.000163	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—bile duct cancer	0.000161	0.000161	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—bile duct cancer	0.000159	0.000159	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—bile duct cancer	0.000158	0.000158	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NRAS—bile duct cancer	0.000158	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—bile duct cancer	0.000158	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—bile duct cancer	0.000158	0.000158	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—bile duct cancer	0.000156	0.000156	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EGFR—bile duct cancer	0.000155	0.000155	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—bile duct cancer	0.000152	0.000152	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—bile duct cancer	0.000151	0.000151	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—bile duct cancer	0.000151	0.000151	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—bile duct cancer	0.000151	0.000151	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—bile duct cancer	0.00015	0.00015	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—bile duct cancer	0.000149	0.000149	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—bile duct cancer	0.000147	0.000147	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NRAS—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EGFR—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—bile duct cancer	0.000142	0.000142	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—bile duct cancer	0.00014	0.00014	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NRAS—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NRAS—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—bile duct cancer	0.000136	0.000136	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—bile duct cancer	0.000136	0.000136	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—bile duct cancer	0.000134	0.000134	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—bile duct cancer	0.000134	0.000134	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EGFR—bile duct cancer	0.000131	0.000131	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EGFR—bile duct cancer	0.000127	0.000127	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EGFR—bile duct cancer	0.000127	0.000127	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—bile duct cancer	0.000124	0.000124	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—bile duct cancer	0.000124	0.000124	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—bile duct cancer	0.000121	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—bile duct cancer	0.00012	0.00012	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—bile duct cancer	0.00012	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—bile duct cancer	0.000119	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—bile duct cancer	0.000116	0.000116	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—bile duct cancer	0.000111	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—bile duct cancer	0.00011	0.00011	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—bile duct cancer	0.000105	0.000105	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—bile duct cancer	0.000103	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—bile duct cancer	0.000102	0.000102	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—bile duct cancer	0.000102	0.000102	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—bile duct cancer	0.000101	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—bile duct cancer	9.76e-05	9.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—bile duct cancer	9.76e-05	9.76e-05	CbGpPWpGaD
